Add Glaxosmithkline to quick picks

Glaxosmithkline Share Price (GSK)



Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,742.00Bid: 1,744.50Ask: 1,745.00Change: -31.00 (-1.75%)Faller - Glaxosmithkline
Spread: 0.50Spread as %: 0.03%Open: 1,752.50High: 1,759.50Low: 1,733.50Yesterday’s Close: 1,773.00

GLAXOSMITHKLINE PLC ORD 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350
Glaxosmithkline is part of the Pharmaceuticals & Biotechnology sector

Glaxosmithkline has a share of around 5% of the world’s pharmaceutical market, aiming to tackle 3 of the ‘priority’ diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.



Intraday Glaxosmithkline Share Chart


Intraday Glaxosmithkline Share Price Chart


Share Price SpacerPrice
1742.00

Share Price SpacerBid
1744.50

Share Price SpacerAsk
1745.00

Share Price SpacerChange
-1.75%Faller - Glaxosmithkline-31.00

Share Price SpacerVolume
7,620,228

Share Price SpacerOpen
1,752.50

Share Price SpacerHigh
1,759.50

Share Price SpacerLow
1,733.50

Share Price SpacerClose
1,773.00

Share Price SpacerCurrency
GBX

3 Month Glaxosmithkline Share Graph


3 Month Glaxosmithkline Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,927.46m £85,836.34m 2,000

52 Week High 1,773.00 52 Week High Date 22-MAY-2013
52 Week Low 1,314.00 52 Week Low Date 19-NOV-2012

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
8,404 5,082,748 2,488,009 18.751 92.90 74.00 4.25


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Tesco, Vodafone Grp., Royal Bank Scot, Bp

Users who hold GSK also hold: Lloyds Grp., Bp, Vodafone Grp., Tesco, National Grid


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-May-13
16:35:01
1,742.00
1,648
Sell* 
1,744.50
1,745.00
28.71k
Trade Type:
Ordinary
Deletion

23-May-13
16:35:01
1,742.00
3,007
Sell* 
1,744.50
1,745.00
52.38k
Trade Type:
Ordinary
Deletion

23-May-13
16:35:05
1,742.00
2,241,045
Sell* 
1,742.00
1,743.00
39.039M
UT 
Trade Type:
Uncrossing Trade


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
16-May-13Transfer To
Trade Notifier Information for GlaxoSmithKline
Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade.
 Sir Andrew P Witty
1723.58GBX6700
16-May-13Transfer From
Trade Notifier Information for GlaxoSmithKline
Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade.
 Sir Andrew P Witty
1723.64GBX6640
16-May-13Transfer To
Trade Notifier Information for GlaxoSmithKline
Sir Andrew P Witty held the position of CEO at GlaxoSmithKline at the time of this trade.
 Sir Andrew P Witty
01,0000
View more Glaxosmithkline directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Wed 07:23
NumptyClub
RE: FTSE P/E 14.7
1,742.00
Hold

Interesting post, thanks.
16 May '13
driftking27
FTSE P/E 14.7
1,707.50
Hold

Remember you are trying to beat the FTSE on a P/E, and also keep risk to a mimum, and dividends mean nothing. If you invest in a high dividend player like this and the markets plummet on bad news, this share goes down with them as well. It will generally take twice as long for this to steam ahead as others to get back to the same footing as before.
16 May '13
driftking27
accumulate shares
1,707.50
Hold

If you hold this share, like I have for 4.5years, accumulate shares on a dip if you like GSK. It is an expensive stock to peers, and I can only see single digit growth. I own Novartis ADR for nearly 6years and things only get better with this bemometh, also JNJ and very small holding of 250 in AZN.
12 May '13
chris47
barchart
1,670.00
Hold

http://www.barchart.com/opinions/stocks/GSK.LS
10 May '13
chris47
1688
1,670.00
Strong Buy

back at 1688 if you include the divi
10 May '13
chris47
sweet news
1,670.00
Strong Buy

"The FDA approval of BREO ELLIPTA brings an important inhaled, once-daily maintenance therapeutic option to COPD patients and doctors across the United States," said Rick E Winningham, Chief Executive Officer of Theravance. "After more than a decade of joint respiratory research and development, the approval is a very important milestone for Theravance and GSK."

Share prices shown are taken at time of message posting.
NEWThread ViewThread View
View more share chat for Glaxosmithkline (GSK) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

GLAXOSMITHKLINE PLC ORD 25P home pageWebsite: GLAXOSMITHKLINE PLC ORD 25P
Website Description: GlaxoSmithKline - Redirect



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.